Alan Montgomery
Direktor/Vorstandsmitglied bei XENCOR, INC.
Vermögen: - $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bassil Dahiyat | M | 53 | 27 Jahre | |
| Linden Rhoads | F | - |
W Fund Management LLC
 W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | 11 Jahre |
| Chad Waite | M | 69 |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Samuel R. Browd | M | - |
Vicis LLC
 Vicis LLC Recreational ProductsConsumer Durables Vicis LLC designs and manufactures football helmets that mitigate linear and rotational impact forces. The company was founded by Samuel R. Browd, David L. Marver, Jonathan Posner and Per Reinhall in 2013 and is headquartered in Seattle, WA. | 11 Jahre |
| Per Reinhall | M | - |
Vicis LLC
Vicis LLC Recreational ProductsConsumer Durables Vicis LLC designs and manufactures football helmets that mitigate linear and rotational impact forces. The company was founded by Samuel R. Browd, David L. Marver, Jonathan Posner and Per Reinhall in 2013 and is headquartered in Seattle, WA. | 11 Jahre |
| Will Poole | M | - |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | 9 Jahre |
| Jeff Canin | M | - |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | 7 Jahre |
| Nancy Valente | M | 66 | 2 Jahre | |
| Kevin Gorman | M | 66 | 7 Jahre | |
| Ellen Feigal | M | 69 | 6 Jahre | |
| Lyn Baranowski | F | - |
Avalyn Pharma, Inc.
 Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 2 Jahre |
| Kurt Gustafson | M | 56 | 10 Jahre | |
| Lonnie S. Edelheit | M | - |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Scott Jacobson | M | 47 |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Thomas J. Clement | M | 67 |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Celia Eckert | F | 52 | 5 Jahre | |
| Patrick Ennis | M | 61 |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Christopher H. Porter | M | 81 |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Steven Gillis | M | 71 |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Richard Ranieri | M | 71 | 7 Jahre | |
| Dagmar Rosa-Bjorkeson | F | 60 | 5 Jahre | |
| Roger K. Cady | M | - | 8 Jahre | |
| David Szymkowski | M | 60 | 22 Jahre | |
| Frank Walters | M | - |
Vicis LLC
Vicis LLC Recreational ProductsConsumer Durables Vicis LLC designs and manufactures football helmets that mitigate linear and rotational impact forces. The company was founded by Samuel R. Browd, David L. Marver, Jonathan Posner and Per Reinhall in 2013 and is headquartered in Seattle, WA. | - |
| Raphael Clynes | M | - | 7 Jahre | |
| Jeremy Grunstein | M | - | 5 Jahre | |
| Charles Liles | M | - | - | |
| Ming Cheah | M | - |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 2 Jahre |
| Joe Wallin | M | - |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | 9 Jahre |
| Lynnette Frank | F | 55 |
Vicis LLC
Vicis LLC Recreational ProductsConsumer Durables Vicis LLC designs and manufactures football helmets that mitigate linear and rotational impact forces. The company was founded by Samuel R. Browd, David L. Marver, Jonathan Posner and Per Reinhall in 2013 and is headquartered in Seattle, WA. | - |
| Dane Leone | M | - | - | |
| Barbara Klencke | M | 66 | 1 Jahre | |
| Niall O'Donnell | M | 51 |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 7 Jahre |
| John Bjornson | M | - |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | 10 Jahre |
| Ketan Patel | M | 49 |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 7 Jahre |
| Linda Higgins | M | 62 | 14 Jahre | |
| John Desjarlais | M | 59 | 23 Jahre | |
| Dan Kranzler | M | - |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Loretta L. Little | F | - |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Ron Howell | M | - |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Heather Elizabeth Preston | M | 58 |
Avalyn Pharma, Inc.
Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA. | 7 Jahre |
| Troy Cichos | M | - |
W Fund Management LLC
W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington. | - |
| Kirk Rosemark | M | - | - | |
| William Ayer | M | 69 |
Vicis LLC
Vicis LLC Recreational ProductsConsumer Durables Vicis LLC designs and manufactures football helmets that mitigate linear and rotational impact forces. The company was founded by Samuel R. Browd, David L. Marver, Jonathan Posner and Per Reinhall in 2013 and is headquartered in Seattle, WA. | - |
| Jennifer Sandoz | F | - | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mark Litton | M | 56 | 14 Jahre | |
| Melissa Yeager | F | - |
Corus Pharma, Inc.
 Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA.
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | 16 Jahre |
| Bruce Carter | M | 80 |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 19 Jahre |
| Randall Schatzman | M | 69 | 14 Jahre | |
| Douglas Williams | M | 66 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 6 Jahre |
| Jeffrey Galik | M | - |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | - |
| Lloyd Rowland | M | 67 | 3 Jahre | |
| Scott A. Kelly | M | 54 | 5 Jahre | |
| Kevin Chow | M | 54 | 7 Jahre | |
| Robert Azelby | M | 56 | 1 Jahre | |
| James Johnson | M | 67 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | 9 Jahre |
| John Kuch | M | 64 | 24 Jahre | |
| Paul Cleveland | M | 67 | - | |
| Jeremy Charles Green | M | 49 | - | |
| Yujiro Hata | M | 49 | 7 Jahre | |
| Nancy L. McKinley | F | - |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | 7 Jahre |
| Kirby Lee Cramer | M | 87 |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | - |
| Paul Carter | M | 63 | 4 Jahre | |
| Robert F. Baltera | M | 58 | 4 Jahre | |
| P. Campisi | M | 63 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | - |
| John McHutchison | M | 66 | 9 Jahre | |
| Carl Dockery | M | 61 | 5 Jahre | |
| David Walsey | M | - | - | |
| Richard Whitley | M | 78 | 13 Jahre | |
| Peter Bisgaard | M | 50 | 3 Jahre | |
| Stephen M. Dow | M | 68 | 13 Jahre | |
| Carla A. Hills | F | 90 | - | |
| Jeremy Levin | M | 70 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | - |
| Robin Washington | F | 60 | 11 Jahre | |
| Per Wold-Olsen | M | 76 | - | |
| Gary Bridger | M | 61 | 3 Jahre | |
| Alan R. Meyer | M | - |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | - |
| Denis Burger | M | 80 | 4 Jahre | |
| Wendy Yarno | F | 68 | - | |
| Deepa Pakianathan | M | 59 | 6 Jahre | |
| Jonathan Fleming | M | 66 | 2 Jahre | |
| Iain W. Duncan | M | - |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | 7 Jahre |
| Jonathan Mow | M | 59 |
Corus Pharma, Inc.
Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA. | 5 Jahre |
| Kevin Lofton | M | 69 | 15 Jahre | |
| Shashi Karan | M | 70 |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | 8 Jahre |
| Andrew Aristidou | M | - | - | |
| Hunter Gillies | M | 58 | 5 Jahre | |
| Carla Fiankan | F | - | 7 Jahre | |
| Stephen Cheng | M | - | 7 Jahre | |
| Mani Subramanian | M | - | 9 Jahre | |
| Michael Hongjie Lan | M | 56 | - | |
| Noreen Henig | M | 59 | 6 Jahre | |
| Uri Lopatin | M | 52 | 2 Jahre | |
| Jung Choi | F | 54 | 8 Jahre | |
| Christopher Griffith | M | 47 | 5 Jahre | |
| Scott Ogg | M | 57 | 2 Jahre | |
| Seigo Izumo | M | - | - | |
| Steven Pfeiffer | M | 48 | 4 Jahre | |
| Anthony D. Caracciolo | M | 68 | 13 Jahre | |
| Pawel Trawkowski | M | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Alan Montgomery
- Persönliches Netzwerk
